0001382963-18-000144.txt : 20181107
0001382963-18-000144.hdr.sgml : 20181107
20181107182413
ACCESSION NUMBER: 0001382963-18-000144
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181105
FILED AS OF DATE: 20181107
DATE AS OF CHANGE: 20181107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FOEHR MATTHEW W
CENTRAL INDEX KEY: 0001237556
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37428
FILM NUMBER: 181167723
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES RD #200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RITTER PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001460702
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263474527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1880 CENTURY PARK EAST, SUITE 1000
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
BUSINESS PHONE: 310-203-1000
MAIL ADDRESS:
STREET 1: 1880 CENTURY PARK EAST, SUITE 1000
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-11-05
0001460702
RITTER PHARMACEUTICALS INC
RTTR
0001237556
FOEHR MATTHEW W
RITTER PHARMACEUTICALS, INC.
1880 CENTURY PARK EAST, SUITE 1000
LOS ANGELES,
CA
90067
1
0
0
0
Series B convertible preferred stock
1.30
2018-11-05
4
P
0
100
A
2018-11-05
Common Stock
76923
100
D
Warrant Shares (right to buy)
1.30
2018-11-05
4
P
0
38461
A
2018-11-05
2023-11-05
Common Stock
38461
38461
D
The Series B convertible preferred stock has no expiration date.
The Reporting Person purchased the shares of Series B convertible preferred stock (the "Series B Shares") from the Issuer in a private placement by the Issuer at a stated price of $1,000 per share and received, in addition to the Series B Shares, a warrant to purchase a number of shares of common stock equal to 50% of the aggregate number of shares of common stock into which his Series B Shares are initally convertible, for no additional consideration.
/s/Andrew J. Ritter, attorney-in-fact
2018-11-07